BALLATER SURGERY — All Prescriptions & Medications — Page 5
Practice Code: G84040 | ORPINGTON, BR6 0DP
Showing results 201-250 of 545
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Fluticasone propionate (Nasal) | 88 | 308 | £1.2K | -39.6% ▼ |
| Typhoid | 85 | 85 | £880 | -5.6% ▼ |
| 85 | 88 | £95 | -61.4% ▼ | |
| Oxybutynin | 81 | 8,036 | £197 | -57.5% ▼ |
| Clobetasol propionate | 81 | 6,320 | £496 | -40.6% ▼ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 79 | 103 | £4.6K | -52.8% ▼ |
| Chlorphenamine maleate | 79 | 8,702 | £243 | -28.4% ▼ |
| Diclofenac diethyl | 79 | 7,900 | £437 | -77.8% ▼ |
| Betamethasone esters | 79 | 6,860 | £816 | +30.9% ▲ |
| Irbesartan | 78 | 5,320 | £394 | -68.0% ▼ |
| Beclometasone dipropionate | 78 | 109 | £335 | -63.7% ▼ |
| Lacosamide | 77 | 7,224 | £4.2K | +43.3% ▲ |
| Oxytetracycline | 77 | 9,988 | £3.7K | +198.1% ▲ |
| Pancreatin | 75 | 23.9K | £9.6K | -32.5% ▼ |
| Enalapril maleate | 75 | 4,396 | £193 | -58.3% ▼ |
| Metronidazole | 75 | 1,351 | £198 | +14.1% ▲ |
| Gliclazide | 75 | 5,215 | £205 | -91.2% ▼ |
| Hepatitis A | 75 | 75 | £1.5K | -1.2% vs avg |
| 75 | 12.1K | £518 | -72.9% ▼ | |
| Brinzolamide | 74 | 850 | £602 | -43.0% ▼ |
| Hydrocortisone acetate | 74 | 2,460 | £470 | +12.1% ▲ |
| Adapalene and benzoyl peroxide | 73 | 3,600 | £1.6K | +36.7% ▲ |
| Clonazepam | 72 | 3,284 | £409 | -53.8% ▼ |
| Carbimazole | 71 | 5,672 | £609 | -37.1% ▼ |
| Azathioprine | 70 | 4,758 | £107 | -35.4% ▼ |
| Sodium bicarbonate | 70 | 18.2K | £810 | -24.3% ▼ |
| Sotalol hydrochloride | 69 | 9,268 | £294 | -1.9% vs avg |
| Clotrimazole | 69 | 1,188 | £587 | -37.5% ▼ |
| Colchicine | 69 | 4,224 | £80 | -11.5% ▼ |
| Testosterone | 68 | 3,588 | £2.4K | -10.9% ▼ |
| 68 | 7,750 | £1.0K | +41.0% ▲ | |
| Risperidone | 67 | 2,315 | £1.3K | -73.5% ▼ |
| Cefalexin | 67 | 2,016 | £191 | -42.4% ▼ |
| Goserelin acetate | 67 | 67 | £8.9K | +52.1% ▲ |
| Powder extensively hydrolysed formula (0913101) | 66 | 179.2K | £5.4K | -8.4% ▼ |
| 66 | 11.4K | £21.5K | +35.4% ▲ | |
| Tapentadol | 65 | 4,676 | £3.1K | +57.9% ▲ |
| Carvedilol | 64 | 5,264 | £194 | -43.6% ▼ |
| Neomycin sulfate | 64 | 1,140 | £144 | +8.0% ▲ |
| Bisacodyl | 63 | 1,520 | £103 | -51.9% ▼ |
| Timolol and travoprost | 63 | 333 | £1.4K | +95.0% ▲ |
| Erythromycin | 62 | 4,116 | £1.3K | +79.0% ▲ |
| Loratadine | 61 | 5,276 | £124 | -70.8% ▼ |
| Fenofibrate | 60 | 2,044 | £226 | -38.0% ▼ |
| Procyclidine hydrochloride | 60 | 3,616 | £139 | -57.6% ▼ |
| Trospium chloride | 60 | 1,372 | £1.1K | +17.5% ▲ |
| Tamoxifen citrate | 60 | 4,136 | £455 | -27.1% ▼ |
| Alfacalcidol | 60 | 3,330 | £707 | -51.5% ▼ |
| Lithium carbonate | 59 | 3,765 | £722 | -53.5% ▼ |
| Tolterodine | 59 | 2,744 | £858 | -60.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.